{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:11:43Z","timestamp":1780575103045,"version":"3.54.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00210-025-04422-2","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T01:33:45Z","timestamp":1751074425000},"page":"16401-16414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of calcium channel blockers in migraine management; a systematic review"],"prefix":"10.1007","volume":"398","author":[{"given":"Hamed","family":"Ghiami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadsalman","family":"Parsapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahba","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Omidkhoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Arasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"7","key":"4422_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS (2021) The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache 61(7):1021\u20131039. https:\/\/doi.org\/10.1111\/head.14153","journal-title":"Headache"},{"key":"4422_CR2","doi-asserted-by":"publisher","unstructured":"al Deeb, S. M., Biary, N., Bahou, Y., al Jaberi, M., & Khoja, W. (1992). Flunarizine in migraine: a double-blind placebo-controlled study (in a Saudi population). Headache, 32(9):461\u2013462. https:\/\/doi.org\/10.1111\/j.1526-4610.1992.hed3209461.x","DOI":"10.1111\/j.1526-4610.1992.hed3209461.x"},{"issue":"4","key":"4422_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1526-4610.1989.hed22904215.x","volume":"29","author":"GW Albers","year":"1989","unstructured":"Albers GW, Simon LT, Hamik A, Peroutka SJ (1989) Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 29(4):215\u2013218. https:\/\/doi.org\/10.1111\/j.1526-4610.1989.hed22904215.x","journal-title":"Headache"},{"issue":"2\u20133","key":"4422_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-2999(91)90526-v","volume":"197","author":"C Ambrosio","year":"1991","unstructured":"Ambrosio C, Stefanini E (1991) Interaction of flunarizine with dopamine D2 and D1 receptors. Eur J Pharmacol 197(2\u20133):221\u2013223. https:\/\/doi.org\/10.1016\/0014-2999(91)90526-v","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4422_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1526-4610.1983.hed2302070.x","volume":"23","author":"WK Amery","year":"1983","unstructured":"Amery WK (1983) Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine. Headache 23(2):70\u201374. https:\/\/doi.org\/10.1111\/j.1526-4610.1983.hed2302070.x","journal-title":"Headache"},{"issue":"5","key":"4422_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1526-4610.1985.hed2505249.x","volume":"25","author":"WK Amery","year":"1985","unstructured":"Amery WK, Caers LI, Aerts TJ (1985) Flunarizine, a calcium entry blocker in migraine prophylaxis. Headache 25(5):249\u2013254. https:\/\/doi.org\/10.1111\/j.1526-4610.1985.hed2505249.x","journal-title":"Headache"},{"issue":"4","key":"4422_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1468-2982.1988.0804269.x","volume":"8","author":"E Ansell","year":"1988","unstructured":"Ansell E, Fazzone T, Festenstein R, Johnson ES, Thavapalan M, Wilkinson M, Wozniak I (1988) Nimodipine in migraine prophylaxis. Cephalalgia 8(4):269\u2013272. https:\/\/doi.org\/10.1046\/j.1468-2982.1988.0804269.x","journal-title":"Cephalalgia"},{"issue":"1","key":"4422_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0014-2999(97)10103-0","volume":"329","author":"K Ayajiki","year":"1997","unstructured":"Ayajiki K, Okamura T, Toda N (1997) Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries. Eur J Pharmacol 329(1):49\u201353. https:\/\/doi.org\/10.1016\/s0014-2999(97)10103-0","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4422_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1526-4610.1992.hed3208390.x","volume":"32","author":"P Bassi","year":"1992","unstructured":"Bassi P, Brunati L, Rapuzzi B, Alberti E, Mangoni A (1992) Low dose flunarizine in the prophylaxis of migraine. Headache 32(8):390\u2013392. https:\/\/doi.org\/10.1111\/j.1526-4610.1992.hed3208390.x","journal-title":"Headache"},{"key":"4422_CR10","doi-asserted-by":"publisher","unstructured":"Battistella, P. A., Ruffilli, R., Moro, R., Fabiani, M., Bertoli, S., Antolini, A., & Zacchelo, F. (1990). A Placebo\u2010Controlled Crossover Trial of Nimodipine in Pediatric Migraine. Headache: The Journal of Head and Face Pain, 30(5), 264\u2013268. https:\/\/doi.org\/10.1111\/j.1526-4610.1990.hed3005264.x","DOI":"10.1111\/j.1526-4610.1990.hed3005264.x"},{"issue":"Suppl 10","key":"4422_CR11","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1097\/00005344-199118101-00019","volume":"18","author":"GE Billman","year":"1991","unstructured":"Billman GE (1991) The antiarrhythmic and antifibrillatory effects of calcium antagonists. J Cardiovasc Pharmacol 18(Suppl 10):S107-117","journal-title":"J Cardiovasc Pharmacol"},{"key":"4422_CR12","doi-asserted-by":"publisher","unstructured":"Bono, G., Manzoni, G. C., Martucci, N., Baldrati, A., Farina, S., Cassabgi, F., . . . Nappi, G. (1985). Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up. Cephalalgia, 5 Suppl 2, 155\u2013158. https:\/\/doi.org\/10.1177\/03331024850050s229","DOI":"10.1177\/03331024850050s229"},{"issue":"5","key":"4422_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1526-4610.1986.hed2605227.x","volume":"26","author":"S Bonuso","year":"1986","unstructured":"Bonuso S, Di Stasio E, Marano E, Sorge F, Leo A (1986) Sublingual flunarizine: a new effective management of the migraine attack. A Comparison versus Ergotamine Headache 26(5):227\u2013230. https:\/\/doi.org\/10.1111\/j.1526-4610.1986.hed2605227.x","journal-title":"A Comparison versus Ergotamine Headache"},{"issue":"3b","key":"4422_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1590\/s0004-282x1997000400003","volume":"55","author":"CA Bordini","year":"1997","unstructured":"Bordini CA, Arruda MA, Ciciarelli MC, Speciali JG (1997) Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A Double-Blind Trial Arq Neuropsiquiatr 55(3b):536\u2013541. https:\/\/doi.org\/10.1590\/s0004-282x1997000400003","journal-title":"A Double-Blind Trial Arq Neuropsiquiatr"},{"issue":"4237","key":"4422_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1126\/science.130678","volume":"192","author":"ST Breisch","year":"1976","unstructured":"Breisch ST, Zemlan FP, Hoebel BG (1976) Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine. Science 192(4237):382\u2013385. https:\/\/doi.org\/10.1126\/science.130678","journal-title":"Science"},{"key":"4422_CR16","doi-asserted-by":"publisher","unstructured":"Bussone, G., Baldini, S., D'Andrea, G., Cananzi, A., Frediani, F., Caresia, L., . . . Boiardi, A. (1987). Nimodipine versus Flunarizine in Common Migraine: A Controlled Pilot Trial. Headache: The Journal of Head and Face Pain, 27(2), 76\u201379. https:\/\/doi.org\/10.1111\/j.1526-4610.1987.hed2702076.x","DOI":"10.1111\/j.1526-4610.1987.hed2702076.x"},{"key":"4422_CR17","doi-asserted-by":"publisher","unstructured":"Caponnetto, V., Deodato, M., Robotti, M., Koutsokera, M., Pozzilli, V., Galati, C., . . . Raggi, A. (2021). Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain, 22(1), 71. https:\/\/doi.org\/10.1186\/s10194-021-01281-z","DOI":"10.1186\/s10194-021-01281-z"},{"issue":"1","key":"4422_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1468-2982.1986.0601015.x","volume":"6","author":"R Cerbo","year":"1986","unstructured":"Cerbo R, Casacchia M, Formisano R, Feliciani M, Cusimano G, Buzzi MG, Agnoli A (1986) Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 6(1):15\u201318. https:\/\/doi.org\/10.1046\/j.1468-2982.1986.0601015.x","journal-title":"Cephalalgia"},{"issue":"2","key":"4422_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/s1474-4422(17)30435-0","volume":"17","author":"A Charles","year":"2018","unstructured":"Charles A (2018) The pathophysiology of migraine: implications for clinical management. Lancet Neurol 17(2):174\u2013182. https:\/\/doi.org\/10.1016\/s1474-4422(17)30435-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"4422_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/oxfordjournals.qjmed.a030141","volume":"89","author":"CE Clarke","year":"1996","unstructured":"Clarke CE, MacMillan L, Sondhi S, Wells NE (1996) Economic and social impact of migraine. QJM 89(1):77\u201384. https:\/\/doi.org\/10.1093\/oxfordjournals.qjmed.a030141","journal-title":"QJM"},{"issue":"1","key":"4422_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13578-023-01091-7","volume":"13","author":"K Conde","year":"2023","unstructured":"Conde K, Fang S, Xu Y (2023) Unraveling the serotonin saga: from discovery to weight regulation and beyond - a comprehensive scientific review. Cell Biosci 13(1):143. https:\/\/doi.org\/10.1186\/s13578-023-01091-7","journal-title":"Cell Biosci"},{"issue":"6","key":"4422_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1023\/a:1008617825269","volume":"19","author":"GH de Bock","year":"1997","unstructured":"de Bock GH, Eelhart J, van Marwijk HW, Tromp TP, Springer MP (1997) A postmarketing study of flunarizine in migraine and vertigo. Pharm World Sci 19(6):269\u2013274. https:\/\/doi.org\/10.1023\/a:1008617825269","journal-title":"Pharm World Sci"},{"key":"4422_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107528","volume":"211","author":"T de Vries","year":"2020","unstructured":"de Vries T, Villal\u00f3n CM, MaassenVanDenBrink A (2020) Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther 211:107528. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107528","journal-title":"Pharmacol Ther"},{"key":"4422_CR24","doi-asserted-by":"publisher","unstructured":"Deligianni, C. I., Sacco, S., Ekizoglu, E., Uluduz, D., Gil-Gouveia, R., MaassenVanDenBrink, A., . . . Lampl, C. (2023). European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine. J Headache Pain, 24(1), 128. https:\/\/doi.org\/10.1186\/s10194-023-01657-3","DOI":"10.1186\/s10194-023-01657-3"},{"issue":"Suppl 1","key":"4422_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A Phase-by-Phase Review of Migraine Pathophysiology. Headache 58(Suppl 1):4\u201316. https:\/\/doi.org\/10.1111\/head.13300","journal-title":"Headache"},{"key":"4422_CR26","doi-asserted-by":"publisher","unstructured":"Eigenbrodt, A. K., Ashina, H., Khan, S., Diener, H. C., Mitsikostas, D. D., Sinclair, A. J., . . . Ashina, M. (2021). Diagnosis and management of migraine in ten steps. Nat Rev Neurol, 17(8), 501\u2013514. https:\/\/doi.org\/10.1038\/s41582-021-00509-5","DOI":"10.1038\/s41582-021-00509-5"},{"issue":"2","key":"4422_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.18203\/2320-6012.ijrms20200276","volume":"8","author":"MV Francis","year":"2020","unstructured":"Francis MV, Singh S, Goyal V, Keny M (2020) Flunarizine: a review of its role in migraine prophylaxis. International Journal of Research in Medical Sciences 8(2):786\u2013793. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20200276","journal-title":"International Journal of Research in Medical Sciences"},{"key":"4422_CR28","doi-asserted-by":"publisher","unstructured":"Frenken, C. W., & Nuijten, S. T. (1984). Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo. Clin Neurol Neurosurg, 86(1):17\u201320. https:\/\/doi.org\/10.1016\/0303-8467(84)90273-7","DOI":"10.1016\/0303-8467(84)90273-7"},{"key":"4422_CR29","doi-asserted-by":"publisher","unstructured":"Garofalo, C., Cristiani, C. M., Ilari, S., Passacatini, L. C., Malafoglia, V., Viglietto, G., . . . Muscoli, C. (2023). Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis. Biomedicines, 11(6). https:\/\/doi.org\/10.3390\/biomedicines11061701","DOI":"10.3390\/biomedicines11061701"},{"issue":"3","key":"4422_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1526-4610.1983.hed2303106.x","volume":"23","author":"HJ Gelmers","year":"1983","unstructured":"Gelmers HJ (1983) Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache 23(3):106\u2013109. https:\/\/doi.org\/10.1111\/j.1526-4610.1983.hed2303106.x","journal-title":"Headache"},{"issue":"1","key":"4422_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1468-2982.1991.1101037.x","volume":"11","author":"WD Gerber","year":"1991","unstructured":"Gerber WD, Diener HC, Scholz E, Niederberger U (1991) Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia 11(1):37\u201345. https:\/\/doi.org\/10.1046\/j.1468-2982.1991.1101037.x","journal-title":"Cephalalgia"},{"key":"4422_CR32","doi-asserted-by":"publisher","unstructured":"Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P. C., Douglas, J. S., . . . Williams, S. V. (2003). ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 41(1), 159\u2013168. https:\/\/doi.org\/10.1016\/s0735-1097(02)02848-6","DOI":"10.1016\/s0735-1097(02)02848-6"},{"issue":"4","key":"4422_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ncl.2019.07.008","volume":"37","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Holland PR (2019) An Update: Pathophysiology of Migraine. Neurol Clin 37(4):651\u2013671. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.008","journal-title":"Neurol Clin"},{"key":"4422_CR34","doi-asserted-by":"publisher","first-page":"629382","DOI":"10.1155\/2015\/629382","volume":"2015","author":"R Gooriah","year":"2015","unstructured":"Gooriah R, Nimeri R, Ahmed F (2015) Evidence-Based Treatments for Adults with Migraine. Pain Res Treat 2015:629382. https:\/\/doi.org\/10.1155\/2015\/629382","journal-title":"Pain Res Treat"},{"issue":"1","key":"4422_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1468-2982.1985.0501039.x","volume":"5","author":"H Havanka-Kanniainen","year":"1985","unstructured":"Havanka-Kanniainen H, Hokkanen E, Myllyl\u00e4 VV (1985) Efficacy of nimodipine in the prophylaxis of migraine. Cephalalgia 5(1):39\u201343. https:\/\/doi.org\/10.1046\/j.1468-2982.1985.0501039.x","journal-title":"Cephalalgia"},{"issue":"1","key":"4422_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1468-2982.1987.0701007.x","volume":"7","author":"H Havanka-Kanniainen","year":"1987","unstructured":"Havanka-Kanniainen H, Hokkanen E, Myllyl\u00e4 VV (1987) Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine. Cephalalgia 7(1):7\u201313. https:\/\/doi.org\/10.1046\/j.1468-2982.1987.0701007.x","journal-title":"Cephalalgia"},{"issue":"5","key":"4422_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the Trigeminal System in Migraine. Headache 59(5):659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache"},{"key":"4422_CR38","doi-asserted-by":"publisher","unstructured":"Jackson, J. L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., . . . Kuester, J. (2015). A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS One, 10(7), e0130733. https:\/\/doi.org\/10.1371\/journal.pone.0130733","DOI":"10.1371\/journal.pone.0130733"},{"issue":"3","key":"4422_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1468-2982.1985.0503125.x","volume":"5","author":"K Jensen","year":"1985","unstructured":"Jensen K, Tfelt-Hansen P, Lauritzen M, Olesen J (1985) Clinical trial of nimodipine for single attacks of classic migraine. Cephalalgia 5(3):125\u2013131. https:\/\/doi.org\/10.1046\/j.1468-2982.1985.0503125.x","journal-title":"Cephalalgia"},{"issue":"6","key":"4422_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/ene.13621","volume":"25","author":"N Karsan","year":"2018","unstructured":"Karsan N, Palethorpe D, Rattanawong W, Marin JC, Bhola R, Goadsby PJ (2018) Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. Eur J Neurol 25(6):811\u2013817. https:\/\/doi.org\/10.1111\/ene.13621","journal-title":"Eur J Neurol"},{"issue":"9","key":"4422_CR41","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00213-022-06181-x","volume":"239","author":"MD Karth","year":"2022","unstructured":"Karth MD, Baugher BJ, Pellechia SA, Huq SN, Warner AK, Karth MM, Sachs BD (2022) Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice. Psychopharmacology 239(9):2975\u20132984. https:\/\/doi.org\/10.1007\/s00213-022-06181-x","journal-title":"Psychopharmacology"},{"key":"4422_CR42","doi-asserted-by":"publisher","unstructured":"Lampl, C., MaassenVanDenBrink, A., Deligianni, C. I., Gil-Gouveia, R., Jassal, T., Sanchez-Del-Rio, M., . . . Sacco, S. (2023). The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain, 24(1), 56. https:\/\/doi.org\/10.1186\/s10194-023-01594-1","DOI":"10.1186\/s10194-023-01594-1"},{"issue":"6","key":"4422_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1526-4610.1993.hed3306335.x","volume":"33","author":"R Lamsudin","year":"1993","unstructured":"Lamsudin R, Sadjimin T (1993) Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine. Headache 33(6):335\u2013338. https:\/\/doi.org\/10.1111\/j.1526-4610.1993.hed3306335.x","journal-title":"Headache"},{"issue":"11","key":"4422_CR44","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s00405-013-2786-4","volume":"271","author":"A Lepcha","year":"2014","unstructured":"Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A (2014) Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol 271(11):2931\u20132936. https:\/\/doi.org\/10.1007\/s00405-013-2786-4","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4422_CR45","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2017.00524","volume":"8","author":"F Liu","year":"2017","unstructured":"Liu F, Ma T, Che X, Wang Q, Yu S (2017) The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine. Front Neurol 8:524. https:\/\/doi.org\/10.3389\/fneur.2017.00524","journal-title":"Front Neurol"},{"key":"4422_CR46","doi-asserted-by":"publisher","unstructured":"Liu, H., Wang, C., Yu, M., Yang, Y., He, Y., Liu, H., . . . Xu, Y. (2021). TPH2 in the Dorsal Raphe Nuclei Regulates Energy Balance in a Sex-Dependent Manner. Endocrinology, 162(1). https:\/\/doi.org\/10.1210\/endocr\/bqaa183","DOI":"10.1210\/endocr\/bqaa183"},{"issue":"6","key":"4422_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1526-4610.1981.hed2106235.x","volume":"21","author":"P Louis","year":"1981","unstructured":"Louis P (1981) A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache 21(6):235\u2013239. https:\/\/doi.org\/10.1111\/j.1526-4610.1981.hed2106235.x","journal-title":"Headache"},{"issue":"4","key":"4422_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1468-2982.1982.0204197.x","volume":"2","author":"P Louis","year":"1982","unstructured":"Louis P, Spierings EL (1982) Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study. Cephalalgia 2(4):197\u2013203. https:\/\/doi.org\/10.1046\/j.1468-2982.1982.0204197.x","journal-title":"Cephalalgia"},{"key":"4422_CR49","doi-asserted-by":"publisher","unstructured":"L\u00fccking, C. H., Oestreich, W., Schmidt, R., & Soyka, D. (1988). Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia, 8 Suppl 8, 21\u201326. https:\/\/doi.org\/10.1177\/03331024880080s805","DOI":"10.1177\/03331024880080s805"},{"issue":"4","key":"4422_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1526-4610.1989.hed22904219.x","volume":"29","author":"HP Ludin","year":"1989","unstructured":"Ludin HP (1989) Flunarizine and propranolol in the treatment of migraine. Headache 29(4):219\u2013224. https:\/\/doi.org\/10.1111\/j.1526-4610.1989.hed22904219.x","journal-title":"Headache"},{"issue":"5a","key":"4422_CR51","doi-asserted-by":"publisher","first-page":"48s","DOI":"10.1016\/0002-9343(91)90486-h","volume":"90","author":"HG Markley","year":"1991","unstructured":"Markley HG (1991) Verapamil and migraine prophylaxis: mechanisms and efficacy. Am J Med 90(5a):48s\u201353s. https:\/\/doi.org\/10.1016\/0002-9343(91)90486-h","journal-title":"Am J Med"},{"key":"4422_CR52","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Lage, J. M. (1988). Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial. Cephalalgia, 8 Suppl 8, 15\u201320. https:\/\/doi.org\/10.1177\/03331024880080s804","DOI":"10.1177\/03331024880080s804"},{"issue":"8","key":"4422_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","volume":"10","author":"GM Mawe","year":"2013","unstructured":"Mawe GM, Hoffman JM (2013) Serotonin signalling in the gut\u2013functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10(8):473\u2013486. https:\/\/doi.org\/10.1038\/nrgastro.2013.105","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"4422_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/03331024850050s225","volume":"5","author":"G Mentenopoulos","year":"1985","unstructured":"Mentenopoulos G, Manafi T, Logothetis J, Bostantzopoulou S (1985) Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation. Cephalalgia 5(Suppl 2):135\u2013140. https:\/\/doi.org\/10.1177\/03331024850050s225","journal-title":"Cephalalgia"},{"issue":"6","key":"4422_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1526-4610.1983.hed2306266.x","volume":"23","author":"JS Meyer","year":"1983","unstructured":"Meyer JS, Hardenberg J (1983) Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache 23(6):266\u2013277. https:\/\/doi.org\/10.1111\/j.1526-4610.1983.hed2306266.x","journal-title":"Headache"},{"issue":"7","key":"4422_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1526-4610.1985.hed2507358.x","volume":"25","author":"JS Meyer","year":"1985","unstructured":"Meyer JS, Nance M, Walker M, Zetusky WJ, Dowell RE Jr (1985) Migraine and cluster headache treatment with calcium antagonists supports a vascular pathogenesis. Headache 25(7):358\u2013367. https:\/\/doi.org\/10.1111\/j.1526-4610.1985.hed2507358.x","journal-title":"Headache"},{"issue":"6","key":"4422_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10194-008-0074-2","volume":"9","author":"C Mj\u00e5set","year":"2008","unstructured":"Mj\u00e5set C, Russell MB (2008) Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine. J Headache Pain 9(6):381\u2013384. https:\/\/doi.org\/10.1007\/s10194-008-0074-2","journal-title":"J Headache Pain"},{"issue":"1","key":"4422_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1526-4610.1987.hed2701051.x","volume":"27","author":"M Molaie","year":"1987","unstructured":"Molaie M, Olson CM, Koch J (1987) The effect of intravenous verapamil on acute migraine headache. Headache 27(1):51\u201353. https:\/\/doi.org\/10.1111\/j.1526-4610.1987.hed2701051.x","journal-title":"Headache"},{"issue":"1\u20132","key":"4422_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000489314","volume":"102","author":"H Mu","year":"2018","unstructured":"Mu H, Wang L (2018) Efficacy of Nimodipine Plus Yufeng Ningxin Tablets for Patients with Frequent Migraine. Pharmacology 102(1\u20132):53\u201357. https:\/\/doi.org\/10.1159\/000489314","journal-title":"Pharmacology"},{"issue":"1","key":"4422_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1345\/aph.18451","volume":"34","author":"TMH Ng","year":"2000","unstructured":"Ng TMH, Kohli A, Fagan SC, Mohamed AE, Geiszt G (2000) The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia. Ann Pharmacother 34(1):39\u201343. https:\/\/doi.org\/10.1345\/aph.18451","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4422_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1468-2982.1996.1605337.x","volume":"16","author":"A Nuti","year":"1996","unstructured":"Nuti A, Lucetti C, Pavese N, Dell\u2019Agnello G, Rossi G, Bonuccelli U (1996) Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients. Cephalalgia 16(5):337\u2013340. https:\/\/doi.org\/10.1046\/j.1468-2982.1996.1605337.x","journal-title":"Cephalalgia"},{"key":"4422_CR62","doi-asserted-by":"publisher","unstructured":"Peles, I., Asla, M., Abayev, M., Gordon, M., Novack, V., Ribalov, R., . . . Ifergane, G. (2022). Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting. J Headache Pain, 23(1), 160. https:\/\/doi.org\/10.1186\/s10194-022-01513-w","DOI":"10.1186\/s10194-022-01513-w"},{"key":"4422_CR63","doi-asserted-by":"publisher","unstructured":"Pfaffenrath, V., Oestreich, W., & Haase, W. (1990). Flunarizine (10 and 20 mg) i.v. versus placebo in the treatment of acute migraine attacks: a multi-centre double-blind study. Cephalalgia, 10(2), 77\u201381. https:\/\/doi.org\/10.1046\/j.1468-2982.1990.1002077.x","DOI":"10.1046\/j.1468-2982.1990.1002077.x"},{"issue":"6","key":"4422_CR64","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0306-3623(91)90593-u","volume":"22","author":"J Popova","year":"1991","unstructured":"Popova J, Staneva-Stoytcheva D, Ivanova E, Tosheva T (1991) The long-term treatment with the Ca(2+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine decreases the activity of 5-HT1 receptors in rat cerebral cortex and hippocampus. Gen Pharmacol 22(6):1147\u20131149. https:\/\/doi.org\/10.1016\/0306-3623(91)90593-u","journal-title":"Gen Pharmacol"},{"key":"4422_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2019.12.014","volume":"107","author":"W Qubty","year":"2020","unstructured":"Qubty W, Patniyot I (2020) Migraine Pathophysiology. Pediatr Neurol 107:1\u20136. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.12.014","journal-title":"Pediatr Neurol"},{"key":"4422_CR66","doi-asserted-by":"publisher","unstructured":"Raggi, A., Leonardi, M., Arruda, M., Caponnetto, V., Castaldo, M., Coppola, G., . . . Martelletti, P. (2024). Hallmarks\u00a0of primary headache: part 1 - migraine. J Headache Pain, 25(1), 189. https:\/\/doi.org\/10.1186\/s10194-024-01889-x","DOI":"10.1186\/s10194-024-01889-x"},{"issue":"2","key":"4422_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1526-4610.1986.hed2602083.x","volume":"26","author":"A Rascol","year":"1986","unstructured":"Rascol A, Montastruc JL, Rascol O (1986) Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Headache 26(2):83\u201385. https:\/\/doi.org\/10.1111\/j.1526-4610.1986.hed2602083.x","journal-title":"Headache"},{"key":"4422_CR68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/b978-0-12-823357-3.00027-6","volume":"199","author":"JC Ray","year":"2024","unstructured":"Ray JC, Matharu M, Hutton E (2024) Relationship of migraine and other forms of chronic pain. Handb Clin Neurol 199:517\u2013524. https:\/\/doi.org\/10.1016\/b978-0-12-823357-3.00027-6","journal-title":"Handb Clin Neurol"},{"issue":"18","key":"4422_CR69","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2021.1640","volume":"325","author":"MS Robbins","year":"2021","unstructured":"Robbins MS (2021) Diagnosis and Management of Headache: A Review. JAMA 325(18):1874\u20131885. https:\/\/doi.org\/10.1001\/jama.2021.1640","journal-title":"JAMA"},{"issue":"3","key":"4422_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/106002808802200301","volume":"22","author":"ME Schuler","year":"1988","unstructured":"Schuler ME, Goldman MP, Munger MA (1988) The role of calcium channel blocking agents in the prevention of migraine. Drug Intell Clin Pharm 22(3):187\u2013191. https:\/\/doi.org\/10.1177\/106002808802200301","journal-title":"Drug Intell Clin Pharm"},{"issue":"1","key":"4422_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1468-2982.1986.0601007.x","volume":"6","author":"PS S\u00f8rensen","year":"1986","unstructured":"S\u00f8rensen PS, Hansen K, Olesen J (1986) A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia 6(1):7\u201314. https:\/\/doi.org\/10.1046\/j.1468-2982.1986.0601007.x","journal-title":"Cephalalgia"},{"key":"4422_CR72","doi-asserted-by":"publisher","unstructured":"S\u00f8rensen, P. S., Larsen, B. H., Rasmussen, M. J., Kinge, E., Iversen, H., Alslev, T., . . . et al. (1991). Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. Headache, 31(10), 650\u2013657. https:\/\/doi.org\/10.1111\/j.1526-4610.1991.hed3110650.x","DOI":"10.1111\/j.1526-4610.1991.hed3110650.x"},{"key":"4422_CR73","doi-asserted-by":"publisher","unstructured":"Sorge, F., & Marano, E. (1985). Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia, 5 Suppl 2, 145\u2013148. https:\/\/doi.org\/10.1177\/03331024850050s227","DOI":"10.1177\/03331024850050s227"},{"key":"4422_CR74","doi-asserted-by":"publisher","unstructured":"Sorge, F., De Simone, R., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988). Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia, 8(1), 1\u20136. https:\/\/doi.org\/10.1046\/j.1468-2982.1988.0801001.x","DOI":"10.1046\/j.1468-2982.1988.0801001.x"},{"key":"4422_CR75","doi-asserted-by":"publisher","unstructured":"Soyka, D., Taneri, Z., Oestreich, W., & Schmidt, R. (1988). Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study. Cephalalgia, 8 Suppl 8, 35\u201340. https:\/\/doi.org\/10.1177\/03331024880080s808","DOI":"10.1177\/03331024880080s808"},{"key":"4422_CR76","doi-asserted-by":"publisher","unstructured":"Soyka, D., Taneri, Z., Oestreich, W., & Schmidt, R. (1989). Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial. Headache, 29(1), 21\u201327. https:\/\/doi.org\/10.1111\/j.1526-4610.1989.hed2901021.x","DOI":"10.1111\/j.1526-4610.1989.hed2901021.x"},{"issue":"7","key":"4422_CR77","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/j.1552-4604.1986.tb02945.x","volume":"26","author":"L Steardo","year":"1986","unstructured":"Steardo L, Marano E, Barone P, Denman DW, Monteleone P, Cardone G (1986) Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide. J Clin Pharmacol 26(7):524\u2013528. https:\/\/doi.org\/10.1002\/j.1552-4604.1986.tb02945.x","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"4422_CR78","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137. https:\/\/doi.org\/10.1186\/s10194-020-01208-0","journal-title":"J Headache Pain"},{"key":"4422_CR79","doi-asserted-by":"publisher","unstructured":"Stewart, D. J., Gelston, A., & Hakim, A. (1988). Effect of Prophylactic Administration of Nimodipine in Patients with Migraine. Headache: The Journal of Head and Face Pain, 28(4), 260\u2013262. https:\/\/doi.org\/10.1111\/j.1526-4610.1988.hed2804260.x","DOI":"10.1111\/j.1526-4610.1988.hed2804260.x"},{"issue":"4","key":"4422_CR80","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/j.pain.0000000000001456","volume":"160","author":"A Stubberud","year":"2019","unstructured":"Stubberud A, Flaaen NM, McCrory DC, Pedersen SA, Linde M (2019) Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis. Pain 160(4):762\u2013772. https:\/\/doi.org\/10.1097\/j.pain.0000000000001456","journal-title":"Pain"},{"issue":"9","key":"4422_CR81","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1526-4610.1988.hed2809602.x","volume":"28","author":"T Takeshima","year":"1988","unstructured":"Takeshima T, Nishikawa S, Takahashi K (1988) Sublingual administration of flunarizine for acute migraine: will flunarizine take the place of ergotamine? Headache 28(9):602\u2013606. https:\/\/doi.org\/10.1111\/j.1526-4610.1988.hed2809602.x","journal-title":"Headache"},{"issue":"3","key":"4422_CR82","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0197-0186(86)90079-3","volume":"9","author":"JE Taylor","year":"1986","unstructured":"Taylor JE, Defeudis FV (1986) Interactions of verapamil, D 600, flunarizine and nifedipine with cerebral histamine-receptors. Neurochem Int 9(3):379\u2013381. https:\/\/doi.org\/10.1016\/0197-0186(86)90079-3","journal-title":"Neurochem Int"},{"key":"4422_CR83","doi-asserted-by":"publisher","unstructured":"Tfelt-Hansen, P., & Tfelt-Hansen, J. (2009). Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache, 49(1), 117\u2013125. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01298.x","DOI":"10.1111\/j.1526-4610.2008.01298.x"},{"issue":"9","key":"4422_CR84","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1526-4610.1991.hed3109613.x","volume":"31","author":"M Thomas","year":"1991","unstructured":"Thomas M, Behari M, Ahuja GK (1991) Flunarizine in migraine prophylaxis: an Indian trial. Headache 31(9):613\u2013615. https:\/\/doi.org\/10.1111\/j.1526-4610.1991.hed3109613.x","journal-title":"Headache"},{"key":"4422_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/b978-0-12-823357-3.00009-4","volume":"199","author":"E Tronvik","year":"2024","unstructured":"Tronvik E, Giri S, Young W (2024) Preventive treatment of migraine: Non-specific oral agents. Handb Clin Neurol 199:67\u201386. https:\/\/doi.org\/10.1016\/b978-0-12-823357-3.00009-4","journal-title":"Handb Clin Neurol"},{"key":"4422_CR86","doi-asserted-by":"publisher","unstructured":"Varrassi, G., Rekatsina, M., Perrot, S., Bouajina, E., Paladini, A., Coaccioli, S., . . . Sarzi Puttini, P. (2023). Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus, 15(9), e44852. https:\/\/doi.org\/10.7759\/cureus.44852","DOI":"10.7759\/cureus.44852"},{"issue":"5","key":"4422_CR87","first-page":"320","volume":"50","author":"L Vijayan","year":"2012","unstructured":"Vijayan L, Bansal D, Ray SB (2012) Nimodipine down-regulates CGRP expression in the rat trigeminal nucleus caudalis. Indian J Exp Biol 50(5):320\u2013324","journal-title":"Indian J Exp Biol"},{"key":"4422_CR88","doi-asserted-by":"publisher","unstructured":"Wells-Gatnik, W. D., & Martelletti, P. (2025). Therapeutic barriers for headache management: issues facing the global north and global south in 2024. Expert Rev Neurother, 1\u20133. https:\/\/doi.org\/10.1080\/14737175.2025.2450647","DOI":"10.1080\/14737175.2025.2450647"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04422-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:29:22Z","timestamp":1764822562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04422-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4422"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04422-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}